Known as a silent killer because men often do not have symptoms in early stages, prostate cancer is the most common form of cancer among men other than skin cancer. In Texas, an estimated 17,230 new cases of prostate cancer will be diagnosed in 2023, with 2,290 expected deaths.
Men age 65 and older account for about 60% of all diagnosed prostate cancer cases, and the likelihood of developing prostate cancer increases after age 50. Additionally, men with a family history of prostate cancer are also at increased risk. If prostate cancer is detected early and before the cancer spreads, patients have a nearly 100% chance of survival after five years.
Treating Prostate Cancer with Proton Therapy
Treatment for prostate cancer varies depending on the stage and grade of the cancer and if it has spread to other body parts. Proton therapy delivers extremely precise, high doses of radiation directly to tumors, working to eliminate cancer cells while minimizing exposure to non-targeted, healthy tissue. This precision benefits patients that require treatment to the prostate gland only or to larger target volumes such as those involving lymph nodes.
Other notable benefits of proton treatment for prostate cancer:
Tips for Screening and Prevention of Prostate Cancer
Men should consider regular prostate screenings beginning at age 50 or in their mid-40’s if they have one or more first degree relatives with prostate cancer (e.g. father, brother, son).
For patients with a new or recurrent prostate cancer diagnosis, a new imaging modality known as prostate-specific membrane antigen (PSMA) PET, is now available at Texas Center for Proton Therapy. The imaging study helps detect prostate cancer cells in the prostate and other parts of the body.
Healthy lifestyle habits also play a key role in preventing prostate cancer early, when it is most treatable, such as:
For more information visit, www.WhatIsProtonTherapy.com.
*This content was featured in the July issue of Texas Month on page 28.
